Call for Abstracts

We encourage young researchers to participate in the meeting by sending oral presentations to be discussed on the two slide seminars sessions.

Please check the guidelines on the website or kindly contact the technical secretariat for further information.

Deadline for abstract submission: September 14th, 2018

Target audience

The meeting is aimed at pathologists-in-training and in-practice, molecular biologists, medical and surgical oncologists, and any other health care professional interested in recent advances in molecular and diagnostic pathology.

Language

Official language of the meeting will be English

Organized by

Accreditation

Continuing Education Credits requested to the Spanish National Health System.

With the collaboration of the Educational Committee of the MD Anderson Cancer Center Madrid.

Venue

Auditorio Rafael del PinoC/ Rafael Calvo, 39AMadrid, Spain

Technical Secretariat

Registrations: www.mdanderson.es/pathologymeeting @MDAnderson_ES

Sponsors

Silver

ADVANCES IN MOLECULAR AND

DIAGNOSTIC PATHOLOGY

2nd PATHOLOGY MEETING

Meeting Directors:

Dr. Joseph Khoury Dr. Juan Fernando García

Madrid, October 3-5, 2018

Under the auspices of

C/ Monasterios de Suso y Yuso 34, 4-14-2 · 28049 Madrid Phone: (+34) 91 372 02 03 e-mail: pathologymeeting@doctaforum.comRegistration: www.mdanderson.es/pathologymeeting

Collaborator

Wednesday, October 3rd, 2018

14:00 - 15:00 Registration & welcome

15:00 - 15:15 Welcome / Overview Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center, Houston, USA Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain

15:15 - 16:05 Opening remarks and keynote lecture Dr. Peter W. T. Pisters, President, The University of Texas MD Anderson Cancer Center, Houston, USA

16:05 - 17:50 SESSION 1. Head and neck tumors Moderator: Dr. M. Pilar López-Criado, MD Anderson Cancer Center Madrid, Spain16:05 - 16:35 Familial non-medullary thyroid tumors Dr. Jose Cameselle, Hospital Clínico Universitario Santiago de Compostela, Spain

16:35 - 17:05 Salivary gland tumors: updated classi�cation, molecular insights, biomarkers and targeted therapy Dr. Diana Bell, The University of Texas MD Anderson Cancer Center, Houston, USA

17:05 - 17:35 Oropharyngeal cancer: two diseases in a very little space Dr. Ricard Mesía, Institut Català d'Oncologia- Badalona, Barcelona, Spain17:35 - 17:50 Discussion

�ursday, October 4th, 2018

08:30 - 08:35 Opening remarks

08:35 - 10:20 SESSION 2. Hematolymphoid tumors Moderator: Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain

08:35 - 09:20 2017 WHO Classi�cation of Hematolymphoid Neoplasms: practical highlights for general pathologists Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center, Houston, USA

09:20 - 10:05 Diagnostic update of aggressive B-cell lymphomas Dr. George Rassidakis, Cancercenter Karolinska, Stockholm, Sweden

10:05 - 10:20 Discussion10:20 - 10:50 Co�ee Break

10:50 - 13:20 SESSION 3. Keynote symposium Moderator: Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center, Houston, USA

10:50 - 11:20 Liquid biopsy for solid tumors - promises and perils Dr. Mark Routbort, The University of Texas MD Anderson Cancer Center, Houston, USA

11:20 - 11:50 Predictive biomarkers for lung cancer immunotherapy Dr. Ignacio I. Wistuba, The University of Texas MD Anderson Cancer Center, Houston, USA

11:50 - 12:20 Integration of Next Generation Sequencing (NGS in diagnostic molecular pathology Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain12:20 - 12:50 Special Lecture: digital pathology Dr. Juan Antonio Retamero, Hospital Campus de la Salud, Granada, Spain

12:50 - 13:20 Panel discussion forum on "Digital Pathology: potential and future directions" Real world experience with Digital Pathology. Dr. Juan A. Retamero Digital pathology implementation vision in Houston. Dr. Victor Prieto Digital pathology network across the Cancer Network. Dr. Joseph Khoury Bene�ts of a digital pathology network from a member site perspective. Dr. Juan F. García 13:20 - 14:50 Lunch

14:50 - 16:35 SESSION 4. Gastrointestinal tumors Moderator: Dr. Santiago González-Moreno, MD Anderson Cancer Center Madrid, Spain14:50 - 15:20 Hereditary gastric cancer: knowns and unknowns Dr. Fátima Carneiro, Hospital de Sao Joao, Oporto, Portugal

15:20 - 15:50 Updates and issues in appendiceal tumors Dr. Melissa Taggart, The University of Texas MD Anderson Cancer Center, Houston, USA

15:50 - 16:20 Classi�cation and pathology reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: perspective of the surgical oncologist

Dr. Santiago González-Moreno, MD Anderson Cancer Center Madrid, Spain16:20 - 16:35 Discussion

16:35 - 18:35 SESSION 5. Slide seminar Moderator: Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center, Houston, USA Special seminar: four to six cases illustrating the role of molecular pathology in the clinical decision making processes Speakers: Dr. Josepth Khoury, Dr. Juan F. García, Dr. Melissa Taggart, Dr. Diana Bell

Friday, October 5th, 2018

08:30 - 09:20 Plenary Lecture - Integrating combos in routine practice of metastatic renal cell carcinoma: clinic versus pathology selection Dr. Enrique Grande, MD Anderson Cancer Center Madrid, Spain

09:20 - 10:35 SESSION 6. Genitourinary tumors Moderator: Francisco X. Real, Spanish National Cancer Center (CNIO)

09:20 - 09:50 �e evolving scenario of bladder cancer classi�cation Francisco X. Real, Spanish National Cancer Center (CNIO)

09:50 - 10:20 Molecular biology, pathology and natural history of prostate cancer: a unique malignancy Dr. Josep Lloreta, Hospital del Mar, Barcelona, Spain10:20 - 10:35 Discussion10:35 - 11:05 Co�ee Break

11:05 - 12:50 SESSION 7. Breast and gynecological tumors Moderator: Dr. Xavier Matias-Guiu, Hospital Universitari Arnau Vilanova, Lleida, Spain

11:05 - 11:35 Prognostic and predictive laboratory tools for breast cancer Dr. Ayse Sahin, The University of Texas MD Anderson Cancer Center, Houston, USA

11:35 - 12:05 Mesenchymal neoplasms of the gynecological tract: current issues Dr. Anais Malpica, The University of Texas MD Anderson Cancer Center, Houston, USA

12:05 - 12:35 Update on pathology of endometrial carcinoma Dr. Xavier Matias-Guiu, Hospital Universitari Arnau Vilanova, Lleida, Spain

12:35 - 12:50 Discussion12:50 - 14:20 Lunch

14:20 - 15:35 SESSION 8. Skin, so� tissue and bone tumors Moderator: Dr. Victor Prieto, The University of Texas MD Anderson Cancer Center, Houston, USA14:20 - 14:50 Precision medicine does not leave anybody unmoved in the sarcoma �eld Dr. Enrique de Álava, Hospital Virgen del Rocío, Seville, Spain

14:50 - 15:20 Targeted therapies and immunotherapy in melanoma. New hope for patients Dr. Victor Prieto, The University of Texas MD Anderson Cancer Center, Houston, USA

15:20 - 15:35 Discussion

15:35 - 17:35 SESSION 9. Slide seminar Moderator: Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain

Special seminar: four to six cases illustrating the role of molecular pathology in the clinical decision making processes Speakers: Dr. Xavier Matías-Guiu, Dr. Ana Teijo, Dr. Anais Malpica

17:35 - 17:50 Closing Remarks Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain Dr. Joseph Khoury, The University of Texas MD Anderson Cancer Center, Houston, USA

ADVANCES IN MOLECULAR AND

DIAGNOSTIC PATHOLOGY

2nd PATHOLOGY MEETING